188 related articles for article (PubMed ID: 9135153)
21. p53 binds to a constitutively nucleosome free region of the mdm2 gene.
Xiao G; White D; Bargonetti J
Oncogene; 1998 Mar; 16(9):1171-81. PubMed ID: 9528859
[TBL] [Abstract][Full Text] [Related]
22. Cloning of the mouse insulin receptor substrate-3 (mIRS-3) promoter, and its regulation by p53.
Sciacchitano S; Orecchio A; Lavra L; Misiti S; Giacchini A; Zani M; Danese D; Gurtner A; Soddu S; Di Mario U; Andreoli M
Mol Endocrinol; 2002 Jul; 16(7):1577-89. PubMed ID: 12089352
[TBL] [Abstract][Full Text] [Related]
23. Targets for transcriptional activation by wild-type p53: endogenous retroviral LTR, immunoglobulin-like promoter, and an internal promoter of the mdm2 gene.
Barak Y; Lupo A; Zauberman A; Juven T; Aloni-Grinstein R; Gottlieb E; Rotter V; Oren M
Cold Spring Harb Symp Quant Biol; 1994; 59():225-35. PubMed ID: 7587074
[No Abstract] [Full Text] [Related]
24. The high levels of p53 present in adenovirus early region 1-transformed human cells do not cause up-regulation of MDM2 expression.
Grand RJ; Lecane PS; Owen D; Grant ML; Roberts S; Levine AJ; Gallimore PH
Virology; 1995 Jul; 210(2):323-34. PubMed ID: 7618270
[TBL] [Abstract][Full Text] [Related]
25. Analysis of the K-ras and p53 pathways in X-ray-induced lung tumors in the rat.
Belinsky SA; Middleton SK; Picksley SM; Hahn FF; Nikula KJ
Radiat Res; 1996 Apr; 145(4):449-56. PubMed ID: 8600505
[TBL] [Abstract][Full Text] [Related]
26. Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damage.
Kelley LL; Hicks GG; Hsieh FF; Prasher JM; Green WF; Miller MD; Eide EJ; Ruley HE
Oncogene; 1998 Sep; 17(9):1119-30. PubMed ID: 9764822
[TBL] [Abstract][Full Text] [Related]
27. Increased apoptosis induction by 121F mutant p53.
Saller E; Tom E; Brunori M; Otter M; Estreicher A; Mack DH; Iggo R
EMBO J; 1999 Aug; 18(16):4424-37. PubMed ID: 10449408
[TBL] [Abstract][Full Text] [Related]
28. Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site.
Takimoto R; El-Deiry WS
Oncogene; 2000 Mar; 19(14):1735-43. PubMed ID: 10777207
[TBL] [Abstract][Full Text] [Related]
29. Involvement of the Oct-1 regulatory element of the gadd45 promoter in the p53-independent response to ultraviolet irradiation.
Takahashi S; Saito S; Ohtani N; Sakai T
Cancer Res; 2001 Feb; 61(3):1187-95. PubMed ID: 11221850
[TBL] [Abstract][Full Text] [Related]
30. Abrogation of p53 function affects gadd gene responses to DNA base-damaging agents and starvation.
Zhan Q; Fan S; Smith ML; Bae I; Yu K; Alamo I; O'Connor PM; Fornace AJ
DNA Cell Biol; 1996 Oct; 15(10):805-15. PubMed ID: 8892753
[TBL] [Abstract][Full Text] [Related]
31. Mutant p53 proteins stimulate spontaneous and radiation-induced intrachromosomal homologous recombination independently of the alteration of the transactivation activity and of the G1 checkpoint.
Saintigny Y; Rouillard D; Chaput B; Soussi T; Lopez BS
Oncogene; 1999 Jun; 18(24):3553-63. PubMed ID: 10380877
[TBL] [Abstract][Full Text] [Related]
32. mdm2-P2 transcript levels predict the functional activity of the p53 tumor suppressor in primary leukemic cells.
Bull EK; Chakrabarty S; Brodsky I; Haines DS
Oncogene; 1998 Apr; 16(17):2249-57. PubMed ID: 9619834
[TBL] [Abstract][Full Text] [Related]
33. The carboxy-terminal serine 392 phosphorylation site of human p53 is not required for wild-type activities.
Fiscella M; Zambrano N; Ullrich SJ; Unger T; Lin D; Cho B; Mercer WE; Anderson CW; Appella E
Oncogene; 1994 Nov; 9(11):3249-57. PubMed ID: 7936649
[TBL] [Abstract][Full Text] [Related]
34. The p53 targets mdm2 and Fas are not required as mediators of apoptosis in vivo.
Reinke V; Lozano G
Oncogene; 1997 Sep; 15(13):1527-34. PubMed ID: 9380404
[TBL] [Abstract][Full Text] [Related]
35. Hydrocarbon carcinogens induce p53 activity in normal mouse tissue.
Stuart D; Khan QA; Brown R; Dipple A
Cancer Lett; 2001 Nov; 173(2):111-4. PubMed ID: 11597784
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of p73 function by Pifithrin-alpha as revealed by studies in zebrafish embryos.
Davidson W; Ren Q; Kari G; Kashi O; Dicker AP; Rodeck U
Cell Cycle; 2008 May; 7(9):1224-30. PubMed ID: 18418056
[TBL] [Abstract][Full Text] [Related]
37. Mutant p53 accumulates in cycling and proliferating cells in the normal tissues of p53 R172H mutant mice.
Goh AM; Xue Y; Leushacke M; Li L; Wong JS; Chiam PC; Rahmat SA; Mann MB; Mann KM; Barker N; Lozano G; Terzian T; Lane DP
Oncotarget; 2015 Jul; 6(20):17968-80. PubMed ID: 26255629
[TBL] [Abstract][Full Text] [Related]
38. The c-fos proto-oncogene is a target for transactivation by the p53 tumor suppressor.
Elkeles A; Juven-Gershon T; Israeli D; Wilder S; Zalcenstein A; Oren M
Mol Cell Biol; 1999 Apr; 19(4):2594-600. PubMed ID: 10082525
[TBL] [Abstract][Full Text] [Related]
39. The high susceptibility of heterozygous p53(+/-) mice to malformation after foetal irradiation is related to sub-competent apoptosis.
Nomoto S; Ootsuyama A; Shioyama Y; Katsuki M; Kondo S; Norimura T
Int J Radiat Biol; 1998 Oct; 74(4):419-29. PubMed ID: 9798952
[TBL] [Abstract][Full Text] [Related]
40. p53 binding to target sites is dynamically regulated before and after ionizing radiation-mediated DNA damage.
Crosby ME; Oancea M; Almasan A
J Environ Pathol Toxicol Oncol; 2004; 23(1):67-79. PubMed ID: 14994997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
